Phase I study of MGY825 in patients with lung cancer

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504350-36-00

Acronym

CMGY825A12101

Enrollment

Registered

2023-12-12

Start date

2022-11-25

Completion date

2025-10-13

Last updated

2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer with or without NFE2L2/KEAP1/CUL3 mutations in adult patients

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026